GleamWall
中文EN

MMED MiniMed Group, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 2062583 · Fiscal year ends 12/31

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-50.0%
TTM EPS YoY-49.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-8.6%
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets23.3%
Debt / equity0.00x
Current ratio1.81x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-07-312026Q4*2026-04-242026Q32026-01-232026Q2*2025-10-242026Q12025-07-252025Q4*2025-04-252025Q32025-01-242025Q2*2024-10-25
Income statement
Revenue$843.00M$837.00M$790.00M—$723.00M$724.00M$687.00M—
Cost of revenue$378.00M$357.00M$428.00M—$314.00M$318.00M$292.00M—
Gross profit$465.00M$480.00M$362.00M—$409.00M$405.00M$395.00M—
R&D expense$115.00M$99.00M$114.00M—$125.00M$107.00M$112.00M—
SG&A expense$312.00M$299.00M$309.00M—$283.00M$276.00M$268.00M—
Operating income$5.00M-$93.00M-$100.00M—-$13.00M-$148.00M$21.00M—
Pretax income$4.00M-$92.00M-$99.00M—-$13.00M-$148.00M$21.00M—
Income tax$4.00M$93.00M$12.00M—$3.00M$21.00M$28.00M—
Net income$0-$185.00M-$119.00M-$5.00M-$19.00M-$172.00M-$10.00M-$5.00M
EBITDA$46.00M-$54.00M——$26.00M-$110.00M——
EPS (basic)0.00—-0.47—-0.08—-0.04—
EPS (diluted)0.00—-0.47—-0.08—-0.04—
Weighted avg. shares (diluted)281.00M—252.81M—252.80M—252.81M—
Balance sheet
Cash & equivalents$207.00M$298.00M$10.00M—$9.00M$11.00M$10.00M—
Receivables$180.00M$200.00M$653.00M——$570.00M——
Inventory$356.00M$341.00M$408.00M——$311.00M——
Current assets$1.42B$1.35B$1.11B——$939.00M——
PP&E, net$736.00M$711.00M$701.00M——$706.00M——
Goodwill$2.25B$2.26B$2.26B——$2.25B——
Intangibles$100.00M$107.00M$113.00M——$132.00M——
Total assets$4.72B$4.63B$4.34B——$4.20B——
Current liabilities$782.00M$702.00M$696.00M——$710.00M——
Total liabilities$1.10B$1.02B$881.00M——$871.00M——
Shareholders' equity$3.62B$3.61B$3.46B$3.56B$3.54B$3.33B$3.48B$3.46B
Shares outstanding281.21M280.82M———0——
Cash flow statement
Operating cash flow-$49.00M-$170.00M——-$141.00M$83.00M——
Capital expenditure$41.00M$56.00M——$53.00M$57.00M——
Free cash flow-$90.00M-$226.00M——-$194.00M$26.00M——
Investing cash flow-$41.00M-$56.00M——-$63.00M-$57.00M——
Financing cash flow$0$512.00M——$202.00M-$25.00M——
Depreciation & amortization$41.00M$39.00M——$39.00M$38.00M——
Stock-based compensation$10.00M$8.00M$11.00M—$9.00M$9.00M$11.00M—

Free plan shows the latest 8 periods; Pro shows all 9 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.